ArticleBMC psychiatry2026
The effects of stimulant medications on the sleepiness curve of young men with Attention-Deficit Hyperactivity Disorder (ADHD).
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe present study aimed at investigating the effects of sleep deprivation and stimulant medication (methylphenidate and amphetamine) on subjective sleepiness in young adults with ADHD, compared to individuals without ADHD.
methodsFifty-nine young men (age 18-35) of whom 39 were diagnosed with ADHD combined type (ADHD-C) and 20 without ADHD. The participants' sleep was monitored for 5 days via actigraphy. Subsequently, the participants were kept continuously awake in a controlled environment for 25 h (8amtill 9am the next day). Among the ADHD group, 17 participants were medicated with their regular doses of methylphenidate (n = 13) or amphetamine (n = 4) at the start of the experiment (08:00 AM) and again at midnight (00:00), while 22 were unmedicated throughout the study. The sleepiness of the participants was assessed every hour by the Karolinska Sleepiness Scale (KSS) in order to obtain the sleepiness curve of both study groups.
resultsUnmedicated ADHD participants reported significantly higher sleepiness throughout the protocol, especially during nighttime and early morning hours. At the end of the 25-hour wakefulness period, their KSS scores were significantly higher than both the control and medicated ADHD groups. No significant difference was found between the medicated ADHD group and controls. Additionally, 88.2% of unmedicated ADHD participants scored above 7 on the KSS (indicating extreme sleepiness), compared to 55% in controls and 36.9% in the medicated ADHD group.
conclusionsYoung adults with ADHD exhibit heightened vulnerability to sleep deprivation, reflected in elevated subjective sleepiness. Stimulant medications effectively attenuate sleepiness in ADHD participants, aligning their alertness levels with those of neurotypical controls. These findings support models of ADHD involving arousal dysregulation and highlight the dual therapeutic role of stimulants in managing both attentional deficits and sleep-related impairments. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.